阅读说明：本技术 一种治疗幽门螺旋杆菌的复合微生物制剂 (Compound microbial preparation for treating helicobacter pylori ) 是由 王东荣 杜芳 于 2021-01-18 设计创作，主要内容包括：本发明涉及医疗制药的技术领域,特别是涉及一种治疗幽门螺旋杆菌的复合微生物制剂,其缩短治愈疗程,增加康复效率,减少用药周期；其原料为糖10％、纯净水90％,所包含成分为乳酸菌35％-45％、酵母菌15％-25％、光合菌5％-8％、双岐杆菌5％-8％、醋酸菌10％-15％,其中原料和组成成分重量配比为8000：1制作步骤如下：步骤一：取水和糖均匀搅拌,其中糖和水的比例为糖10％、纯净水90％,之后将水温加热至121℃保压保温30分钟；步骤二：将水温降至35℃；步骤三：之后取定量比例的乳酸菌35％-45％、酵母菌15％-25％、光合菌5％-8％、双岐杆菌5％-8％、醋酸菌10％-15％加入到步骤二中均匀搅拌,搅拌完成后的溶剂发酵48小时制得复合微生物制剂；步骤四：将步骤三中制得的复合微生物制剂进行分装。(The invention relates to the technical field of medical pharmacy, in particular to a compound microbial preparation for treating helicobacter pylori, which shortens the treatment course, increases the rehabilitation efficiency and reduces the medication period; the raw materials comprise 10 percent of sugar and 90 percent of purified water, and the components comprise 35 to 45 percent of lactic acid bacteria, 15 to 25 percent of yeast, 5 to 8 percent of photosynthetic bacteria, 5 to 8 percent of bifidobacterium and 10 to 15 percent of acetic acid bacteria, wherein the weight ratio of the raw materials to the components is 8000: 1 the preparation steps are as follows: the method comprises the following steps: uniformly stirring water and sugar, wherein the ratio of sugar to water is 10% of sugar and 90% of purified water, and then heating the water to 121 ℃, maintaining the pressure and preserving the heat for 30 minutes; step two: cooling the water to 35 ℃; step three: then adding 35-45% of lactic acid bacteria, 15-25% of saccharomycetes, 5-8% of photosynthetic bacteria, 5-8% of bifidobacterium and 10-15% of acetic acid bacteria in a quantitative proportion into the second step, uniformly stirring, and fermenting the stirred solvent for 48 hours to obtain the compound microbial preparation; step four: subpackaging the compound microbial preparation prepared in the third step.)

1. The compound microbial preparation for treating helicobacter pylori is characterized in that the raw materials comprise 10% of sugar and 90% of purified water, the components comprise 35% -45% of lactic acid bacteria, 15% -25% of yeast, 5% -8% of photosynthetic bacteria, 5% -8% of bifidobacterium and 10% -15% of acetic acid bacteria, and the weight ratio of the raw materials to the components is 8000: 1

The preparation method comprises the following steps:

the method comprises the following steps: uniformly stirring water and sugar, wherein the ratio of sugar to water is 10% of sugar and 90% of purified water, and then heating the water to 121 ℃, maintaining the pressure and preserving the heat for 30 minutes;

step two: cooling the water to 35 ℃;

step three: then adding 35-45% of lactic acid bacteria, 15-25% of saccharomycetes, 5-8% of photosynthetic bacteria, 5-8% of bifidobacterium and 10-15% of acetic acid bacteria in a quantitative proportion into the second step, uniformly stirring, and fermenting the stirred solvent for 48 hours to obtain the compound microbial preparation;

step four: subpackaging the compound microbial preparation prepared in the third step.

2. The complex microbial preparation for treating helicobacter pylori according to claim 1, wherein the water is used for providing a culture environment for lactic acid bacteria, yeast, photosynthetic bacteria, bifidobacteria and acetic acid bacteria.

3. The complex microbial preparation for treating helicobacter pylori according to claim 1, wherein the sugar is used for rapid propagation of lactic acid bacteria, yeast, photosynthetic bacteria, bifidobacteria and acetic acid bacteria to ensure normal growth of the microorganisms.

4. The complex microbial preparation for treating helicobacter pylori according to claim 1, wherein the lactic acid bacteria and the bifidobacteria are used to produce short-chain fatty acids such as acetic acid, propionic acid and butyric acid, etc., to form an acidic environment in the intestines and stomach, thereby inhibiting the growth of various enterogastritis-causing microorganisms.

5. The complex microbial preparation for treating helicobacter pylori according to claim 1, wherein the yeast is used for improving the gastrointestinal immune system environment and enhancing the resistance of a patient.

6. The complex microbial preparation for treating helicobacter pylori according to claim 1, wherein said photosynthetic bacteria inhibit the growth and propagation of harmful bacteria in the intestines and stomach, and the number of harmful bacteria is reduced.

7. The microbial preparation according to claim 1, wherein the acetic acid bacteria are of the heterotrophic aerobic type, and are effective for oxidizing glucose to gluconic acid and oxidizing alcohol to produce a small amount of acetic acid.

Technical Field

The invention relates to the technical field of medical pharmacy, in particular to a compound microbial preparation for treating helicobacter pylori.

Background

As is well known, a complex microbial preparation for treating helicobacter pylori is a complex microbial preparation for treating helicobacter pylori, which is widely used in the field of medical pharmacy; helicobacter pylori is a bacterium that is helicoidal, micro-anaerobic, and very demanding in terms of growth conditions, and lives in all areas of the stomach and duodenum, and more than 50% of the world population has helicobacter pylori in the upper part of the digestive system, which causes mild chronic inflammation of the gastric mucosa, even gastric and duodenal ulcers and stomach cancer, and more than 80% of carriers do not show symptoms.

Disclosure of Invention

In order to solve the technical problems, the invention provides the compound microbial preparation for treating the helicobacter pylori, which shortens the treatment course, increases the rehabilitation efficiency and reduces the medication period.

The invention relates to a compound microbial preparation for treating helicobacter pylori, which comprises the following raw materials of 10% of sugar and 90% of purified water, and comprises 35% -45% of lactic acid bacteria, 15% -25% of saccharomycetes, 5% -8% of photosynthetic bacteria, 5% -8% of bifidobacterium and 10% -15% of acetic acid bacteria, wherein the weight ratio of the raw materials to the components is 8000: 1.

the preparation method comprises the following steps:

the method comprises the following steps: uniformly stirring water and sugar, wherein the ratio of sugar to water is 10% of sugar and 90% of purified water, and then heating the water to 121 ℃, maintaining the pressure and preserving the heat for 30 minutes;

step two: cooling the water to 35 ℃;

step three: then adding 35-45% of lactic acid bacteria, 15-25% of saccharomycetes, 5-8% of photosynthetic bacteria, 5-8% of bifidobacterium and 10-15% of acetic acid bacteria in a quantitative proportion into the second step, uniformly stirring, and fermenting the stirred solvent for 48 hours to obtain the compound microbial preparation;

step four: subpackaging the compound microbial preparation prepared in the third step.

The water is used for providing a culture environment for lactic acid bacteria, saccharomycetes, photosynthetic bacteria, bifidobacteria and acetic acid bacteria.

The sugar is used for rapid breeding of lactic acid bacteria, saccharomycetes, photosynthetic bacteria, bifidobacteria and acetic acid bacteria, and ensures the normal growth of microorganisms.

The lactobacillus and the bifidobacterium are used for producing short-chain fatty acids such as acetic acid, propionic acid, butyric acid and the like, so that an acid environment is formed in intestines and stomach, and the growth of various enterogastritis pathogenic microorganisms is inhibited.

The composite microbial preparation for treating the helicobacter pylori, disclosed by the invention, is used for improving the environment of a gastrointestinal immune system of a patient and increasing the resistance.

The photosynthetic bacteria inhibit the growth and reproduction of harmful bacteria in intestines and stomach, and reduce the quantity of the harmful bacteria.

The acetic acid bacteria are of an anaerobic aerobic type, mainly have the effect of oxidizing glucose into gluconic acid and can also oxidize alcohol to generate a small amount of acetic acid.

Compared with the prior art, the invention has the beneficial effects that: the treatment period is shortened, the common medicine can be treated about 3 months, i can treat the disease in one week, the rehabilitation efficiency is improved, the medication period is shortened, and the pain period of patients is reduced.

Detailed Description

The following examples are given to further illustrate the embodiments of the present invention. The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.

The invention relates to a compound microbial preparation for treating helicobacter pylori, which comprises the following raw materials of 10% of sugar and 90% of purified water, and comprises 35% -45% of lactic acid bacteria, 15% -25% of saccharomycetes, 5% -8% of photosynthetic bacteria, 5% -8% of bifidobacterium and 10% -15% of acetic acid bacteria, wherein the weight ratio of the raw materials to the components is 8000: 1.

the preparation method comprises the following steps:

the method comprises the following steps: uniformly stirring water and sugar, wherein the ratio of sugar to water is 10% of sugar and 90% of purified water, and then heating the water to 121 ℃, maintaining the pressure and preserving the heat for 30 minutes;

step two: cooling the water to 35 ℃;

step three: then adding 35-45% of lactic acid bacteria, 15-25% of saccharomycetes, 5-8% of photosynthetic bacteria, 5-8% of bifidobacterium and 10-15% of acetic acid bacteria into the second step, uniformly stirring, and fermenting the stirred solvent for 48 hours to obtain the compound microbial preparation

Step four: subpackaging the compound microbial preparation prepared in the third step.

The water is used for providing a culture environment for lactic acid bacteria, saccharomycetes, photosynthetic bacteria, bifidobacteria and acetic acid bacteria.

The sugar is used for rapid breeding of lactic acid bacteria, saccharomycetes, photosynthetic bacteria, bifidobacteria and acetic acid bacteria, and ensures the normal growth of microorganisms.

The lactobacillus and the bifidobacterium are used for producing short-chain fatty acids such as acetic acid, propionic acid, butyric acid and the like, so that an acid environment is formed in intestines and stomach, and the growth of various enterogastritis pathogenic microorganisms is inhibited.

The composite microbial preparation for treating the helicobacter pylori, disclosed by the invention, is used for improving the environment of a gastrointestinal immune system of a patient and increasing the resistance.

The photosynthetic bacteria inhibit the growth and reproduction of harmful bacteria in intestines and stomach, and reduce the quantity of the harmful bacteria.

The acetic acid bacteria are of an anaerobic aerobic type, mainly have the effect of oxidizing glucose into gluconic acid and can also oxidize alcohol to generate a small amount of acetic acid.

Example one

The following examples are given to further illustrate the embodiments of the present invention. The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.

The invention relates to a compound microbial preparation for treating helicobacter pylori, which comprises 10% of sugar and 90% of purified water as raw materials, wherein the components comprise 45% of lactic acid bacteria, 25% of saccharomycetes, 8% of photosynthetic bacteria, 8% of bifidobacterium and 14% of acetic acid bacteria, and the weight ratio of the raw materials to the components is 8000: 1.

the preparation method comprises the following steps:

the method comprises the following steps: uniformly stirring water and sugar, wherein the ratio of sugar to water is 10% of sugar and 90% of purified water, and then heating the water to 121 ℃, maintaining the pressure and preserving the heat for 30 minutes;

step two: cooling the water to 35 ℃;

step three: then adding lactobacillus, microzyme, photosynthetic bacteria, bifidobacterium and acetic acid bacteria in a certain proportion into the second step, uniformly stirring, and fermenting the stirred solvent for 48 hours to obtain the compound microbial preparation;

step four: subpackaging the compound microbial preparation prepared in the third step.

The water is used for providing a culture environment for lactic acid bacteria, saccharomycetes, photosynthetic bacteria, bifidobacteria and acetic acid bacteria.

The sugar is used for rapid breeding of lactic acid bacteria, saccharomycetes, photosynthetic bacteria, bifidobacteria and acetic acid bacteria, and ensures the normal growth of microorganisms.

The lactobacillus and the bifidobacterium are used for producing short-chain fatty acids such as acetic acid, propionic acid, butyric acid and the like, so that an acid environment is formed in intestines and stomach, and the growth of various enterogastritis pathogenic microorganisms is inhibited.

The composite microbial preparation for treating the helicobacter pylori, disclosed by the invention, is used for improving the environment of a gastrointestinal immune system of a patient and increasing the resistance.

The photosynthetic bacteria inhibit the growth and reproduction of harmful bacteria in intestines and stomach, and reduce the quantity of the harmful bacteria.

The acetic acid bacteria are of an anaerobic aerobic type, mainly have the effect of oxidizing glucose into gluconic acid and can also oxidize alcohol to generate a small amount of acetic acid.

Example two

The invention relates to a compound microbial preparation for treating helicobacter pylori, which comprises 10% of sugar and 90% of purified water as raw materials, wherein the components comprise 44% of lactic acid bacteria, 25% of saccharomycetes, 8% of photosynthetic bacteria, 8% of bifidobacterium and 15% of acetic acid bacteria, and the weight ratio of the raw materials to the components is 8000: 1.

the preparation method comprises the following steps:

the method comprises the following steps: uniformly stirring water and sugar, wherein the ratio of sugar to water is 10% of sugar and 90% of purified water, and then heating the water to 121 ℃, maintaining the pressure and preserving the heat for 30 minutes;

step two: cooling the water to 35 ℃;

step three: then adding lactobacillus, microzyme, photosynthetic bacteria, bifidobacterium and acetic acid bacteria in a certain proportion into the second step, uniformly stirring, and fermenting the stirred solvent for 48 hours to obtain the compound microbial preparation;

step four: subpackaging the compound microbial preparation prepared in the third step.

The water is used for providing a culture environment for lactic acid bacteria, saccharomycetes, photosynthetic bacteria, bifidobacteria and acetic acid bacteria.

The sugar is used for rapid breeding of lactic acid bacteria, saccharomycetes, photosynthetic bacteria, bifidobacteria and acetic acid bacteria, and ensures the normal growth of microorganisms.

The lactobacillus and the bifidobacterium are used for producing short-chain fatty acids such as acetic acid, propionic acid, butyric acid and the like, so that an acid environment is formed in intestines and stomach, and the growth of various enterogastritis pathogenic microorganisms is inhibited.

The composite microbial preparation for treating the helicobacter pylori, disclosed by the invention, is used for improving the environment of a gastrointestinal immune system of a patient and increasing the resistance.

The photosynthetic bacteria inhibit the growth and reproduction of harmful bacteria in intestines and stomach, and reduce the quantity of the harmful bacteria.

The acetic acid bacteria are of an anaerobic aerobic type, mainly have the effect of oxidizing glucose into gluconic acid and can also oxidize alcohol to generate a small amount of acetic acid.

Method of administration

When in use, the refrigerated compound microbial preparation is taken out and then directly taken by patients

Although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that various changes in the embodiments and/or modifications of the invention can be made, and equivalents and modifications of some features of the invention can be made without departing from the spirit and scope of the invention.